person · Reporting owner
DelOrefice Christopher
Disclosed activity across 3 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BECTON DICKINSON & COBDX · Entity 2498 | EVP & Chief Financial Officer | November 26, 2025 | December 01, 2025 |
| RESMED INCRMD · Entity 2692 | Director | November 20, 2025 | November 24, 2025 |
| Ulta Beauty, Inc.ULTA · Entity 977 | Chief Financial Officer | March 31, 2026 | April 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BECTON DICKINSON & CO
Report date November 26, 2025 · Filed December 01, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 22,982 |
Ending reported balance
After 2025-11-26 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-11-26 · Grant · Acquired 6,006 · Balance 27,227 F1: Represents shares received upon vesting of performance-based equity awards. Row 2 · 2025-11-26 · Tax withholding · Disposed 4,245 · Balance 22,982 F2: Represents shares withheld for payment of withholding taxes in connection with (A) the vesting of the performance units referred to in footnote (1) and (B) the vesting of restricted stock units previously reported on Table I. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares received upon vesting of performance-based equity awards.
F2: Represents shares withheld for payment of withholding taxes in connection with (A) the vesting of the performance units referred to in footnote (1) and (B) the vesting of restricted stock units previously reported on Table I.
RESMED INC
Report date November 20, 2025 · Filed November 24, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| ResMed Common StockSEC Table I · non-derivative | Direct | 2,423 |
Reported balance
After 2025-11-20 transaction · row 1
1 source rowRow 1 · 2025-11-20 · Grant · Acquired 1,073 · Balance 2,423 F1: Shares awarded represent Restricted Stock Units. The RSUs vest in full on the earlier of 11/11/2026, or the annual meeting of stockholders in the year following the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares awarded represent Restricted Stock Units. The RSUs vest in full on the earlier of 11/11/2026, or the annual meeting of stockholders in the year following the grant date.
Ulta Beauty, Inc.
Report date March 31, 2026 · Filed April 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,693 |
Reported balance
After 2026-03-31 transaction · row 1
1 source rowRow 1 · 2026-03-31 · Grant · Acquired 4,219 · Balance 9,693 F1: Represents grant of 4,219 shares of restricted stock, vesting 100% on March 15, 2029. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $522.71 · Expires 2036-03-31 | Direct | 14,363 |
Reported balance
After 2026-03-31 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-03-31 · Grant · Acquired 14,363 · Balance 14,363 F2: The options, representing an initial right to purchase a total of 14,363 shares, vesting in 25% annual increments beginning March 15, 2027 and each anniversary thereafter through March 15, 2030. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents grant of 4,219 shares of restricted stock, vesting 100% on March 15, 2029.
F2: The options, representing an initial right to purchase a total of 14,363 shares, vesting in 25% annual increments beginning March 15, 2027 and each anniversary thereafter through March 15, 2030.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 31, 2026 Filed Apr 2, 2026 16:45 UTC | Ulta Beauty, Inc. ULTA · Entity 977 | GrantStock Option (right to buy) · Derivative | 14,363 | $0.00 Strike: $522.71 | $0.00 |
DisclosureSEC source: 0000897069-26-000771 · form4.xml · derivative · entry 2 DelOrefice Christopher · CIK 0001881430 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,363 Underlying: Common Stock · 14,363 shares Expires 2036-03-31 F2 · derivative.exercise_date: The options, representing an initial right to purchase a total of 14,363 shares, vesting in 25% annual increments beginning March 15, 2027 and each anniversary thereafter through March 15, 2030. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 16:45 UTC | Ulta Beauty, Inc. ULTA · Entity 977 | GrantCommon Stock | 4,219 | $0.00 | $0.00 |
DisclosureSEC source: 0000897069-26-000771 · form4.xml · nonDerivative · entry 1 DelOrefice Christopher · CIK 0001881430 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,693 F1 · shares: Represents grant of 4,219 shares of restricted stock, vesting 100% on March 15, 2029. Read SEC document |
| December 09, 2025 Filed Dec 10, 2025 16:43 UTC | Ulta Beauty, Inc. ULTA · Entity 977 | GrantCommon Stock | 3,649 | $0.00 | $0.00 |
DisclosureSEC source: 0000897069-25-001790 · form4.xml · nonDerivative · entry 2 DelOrefice Christopher · CIK 0001881430 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,474 F2 · shares: Represents a grant of 3,649 restricted stock units, each representing one share of common stock, vesting 100% on December 9, 2027. Read SEC document |
| December 09, 2025 Filed Dec 10, 2025 16:43 UTC | Ulta Beauty, Inc. ULTA · Entity 977 | GrantCommon Stock | 1,825 | $0.00 | $0.00 |
DisclosureSEC source: 0000897069-25-001790 · form4.xml · nonDerivative · entry 1 DelOrefice Christopher · CIK 0001881430 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,825 F1 · shares: Represents a grant of 1,825 restricted stock units, each representing one share of common stock, vesting 100% on December 9, 2026. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 17:02 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Tax withholdingCommon Stock | 4,245 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-054346 · wk-form4_1764608555.xml · nonDerivative · entry 2 DelOrefice Christopher · CIK 0001881430 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,982 F2 · shares: Represents shares withheld for payment of withholding taxes in connection with (A) the vesting of the performance units referred to in footnote (1) and (B) the vesting of restricted stock units previously reported on Table I. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 17:02 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 6,006 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-054346 · wk-form4_1764608555.xml · nonDerivative · entry 1 DelOrefice Christopher · CIK 0001881430 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,227 F1 · shares: Represents shares received upon vesting of performance-based equity awards. Read SEC document |
| November 20, 2025 Filed Nov 24, 2025 14:49 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 1,073 | $0.00 | $0.00 |
DisclosureSEC source: 0000943819-25-000167 · form4.xml · nonDerivative · entry 1 DelOrefice Christopher · CIK 0001881430 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,423 F1 · kind: Shares awarded represent Restricted Stock Units. The RSUs vest in full on the earlier of 11/11/2026, or the annual meeting of stockholders in the year following the grant date. Read SEC document |
| September 01, 2025 Filed Sep 2, 2025 23:57 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Tax withholdingCommon Stock | 278 | $0.00 | $0.00 |
DisclosureSEC source: 0000010795-25-000091 · wk-form4_1756857449.xml · nonDerivative · entry 1 DelOrefice Christopher · CIK 0001881430 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,221 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units previously reported on Table 1. Read SEC document |
| November 26, 2024 Filed Nov 29, 2024 15:02 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantStock Appreciation Rights · Derivative | 19,138 | $0.00 Strike: $224.25 | $0.00 |
DisclosureSEC source: 0001062993-24-019802 · form4.xml · derivative · entry 4 DelOrefice Christopher · CIK 0001881430 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,138 Underlying: Common Stock · 19,138 shares Expires 2034-11-26 F4 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2025. Read SEC document |
| November 26, 2024 Filed Nov 29, 2024 15:02 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Tax withholdingCommon Stock | 5,192 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-019802 · form4.xml · nonDerivative · entry 3 DelOrefice Christopher · CIK 0001881430 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,499 F3 · shares: Represents shares withheld for payment of withholding taxes in connection with (A) the vesting of the performance units referred to in footnote (2) and (B) the vesting of restricted stock units previously reported on Table I. Read SEC document |
| November 26, 2024 Filed Nov 29, 2024 15:02 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 9,015 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-019802 · form4.xml · nonDerivative · entry 2 DelOrefice Christopher · CIK 0001881430 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,691 F2 · shares: Represents shares received upon vesting of performance-based equity awards. Read SEC document |
| November 26, 2024 Filed Nov 29, 2024 15:02 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 4,884 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-019802 · form4.xml · nonDerivative · entry 1 DelOrefice Christopher · CIK 0001881430 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,676 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Read SEC document |
| November 20, 2024 Filed Nov 22, 2024 21:19 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 1,083 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-027899 · form4.xml · nonDerivative · entry 1 DelOrefice Christopher · CIK 0001881430 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,350 F1 · kind: Shares awarded represent Restricted Stock Units. The RSUs cliff vest on the earlier of 11/11/2025, or the annual shareholder's meeting in the year following the grant date. Read SEC document |
| September 07, 2024 Filed Sep 9, 2024 19:46 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Tax withholdingCommon Stock | 466 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016294 · form4.xml · nonDerivative · entry 1 DelOrefice Christopher · CIK 0001881430 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,792 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units previously reported on Table 1. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 22:30 UTC | RESMED INC RMD · Entity 2692 | GrantResMed Common Stock | 267 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-023595 · form4.xml · nonDerivative · entry 1 DelOrefice Christopher · CIK 0001881430 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 267 F1 · kind: Shares awarded are restricted stock units. The RSUs vest on the first anniversary of the grant date. Read SEC document |
| September 01, 2024 Filed Sep 4, 2024 18:56 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Tax withholdingCommon Stock | 254 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-016074 · form4.xml · nonDerivative · entry 1 DelOrefice Christopher · CIK 0001881430 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,258 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units previously reported on Table 1. Read SEC document |
| November 26, 2023 Filed Nov 29, 2023 01:22 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantStock Appreciation Rights · Derivative | 18,425 | $0.00 Strike: $238.89 | $0.00 |
DisclosureSEC source: 0001062993-23-021555 · form4.xml · derivative · entry 3 DelOrefice Christopher · CIK 0001881430 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,425 Underlying: Common Stock · 18,425 shares Expires 2033-11-26 F3 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2024. Read SEC document |
| November 26, 2023 Filed Nov 29, 2023 01:22 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Tax withholdingCommon Stock | 812 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-021555 · form4.xml · nonDerivative · entry 2 DelOrefice Christopher · CIK 0001881430 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,512 F2 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of previously reported restricted stock unit awards. Read SEC document |
| November 26, 2023 Filed Nov 29, 2023 01:22 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 3,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-021555 · form4.xml · nonDerivative · entry 1 DelOrefice Christopher · CIK 0001881430 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,324 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Read SEC document |
| September 07, 2023 Filed Sep 8, 2023 19:00 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Tax withholdingCommon Stock | 601 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017830 · form4.xml · nonDerivative · entry 1 DelOrefice Christopher · CIK 0001881430 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,999 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of previously reported restricted stock unit awards. Read SEC document |
| September 01, 2023 Filed Sep 5, 2023 19:27 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Tax withholdingCommon Stock | 353 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017512 · form4.xml · nonDerivative · entry 1 DelOrefice Christopher · CIK 0001881430 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,600 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of previously reported restricted stock unit awards. Read SEC document |
| November 26, 2022 Filed Nov 29, 2022 21:34 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantStock Appreciation Rights · Derivative | 18,658 | $0.00 Strike: $227.80 | $0.00 |
DisclosureSEC source: 0001062993-22-022913 · form4.xml · derivative · entry 3 DelOrefice Christopher · CIK 0001881430 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,658 Underlying: Common Stock · 18,658 shares Expires 2032-11-26 F3 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2023. Read SEC document |
| November 26, 2022 Filed Nov 29, 2022 21:34 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Tax withholdingCommon Stock | 269 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-022913 · form4.xml · nonDerivative · entry 2 DelOrefice Christopher · CIK 0001881430 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,953 F2 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of previously reported restricted stock unit awards. Read SEC document |
| November 26, 2022 Filed Nov 29, 2022 21:34 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 3,087 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-022913 · form4.xml · nonDerivative · entry 1 DelOrefice Christopher · CIK 0001881430 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,222 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Read SEC document |
| September 07, 2022 Filed Sep 29, 2022 20:27 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Tax withholdingCommon Stock | 506 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-020057 · form4.xml · nonDerivative · entry 1 DelOrefice Christopher · CIK 0001881430 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,135 F1 · shares: Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units previously reported on Table I. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 16:48 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 2,674 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019179 · form4.xml · nonDerivative · entry 1 DelOrefice Christopher · CIK 0001881430 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,641 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Read SEC document |
| November 26, 2021 Filed Nov 30, 2021 17:38 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantStock Appreciation Rights · Derivative | 18,638 | $0.00 Strike: $245.09 | $0.00 |
DisclosureSEC source: 0001543407-21-000049 · edgar.xml · derivative · entry 2 DelOrefice Christopher · CIK 0001881430 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,638 Underlying: Common Stock · 18,638 shares Expires 2031-11-26 F2 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2022. Read SEC document |
| November 26, 2021 Filed Nov 30, 2021 17:38 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 2,608 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-21-000049 · edgar.xml · nonDerivative · entry 1 DelOrefice Christopher · CIK 0001881430 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,967 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Read SEC document |
| September 07, 2021 Filed Sep 8, 2021 18:09 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 4,359 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-21-000039 · edgar.xml · nonDerivative · entry 1 DelOrefice Christopher · CIK 0001881430 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,359 F1 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.